Clean Vision Corp (CLNV) Financial Statements (2025 and earlier)

Company Profile

Business Address 2711 N. SEPULVEDA BLVD
MANHATTAN BEACH, CA 90266
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 286 - Industrial Organic Chemicals (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2025
MRQ
12/31/2024
12/31/2023
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments886340
Cash and cash equivalent886340
Receivables3871
Other undisclosed current assets2,494442
Total current assets:3,418853
Noncurrent Assets
Operating lease, right-of-use asset  
Property, plant and equipment4,7954,884
Intangible assets, net (including goodwill)4,8554,585
Goodwill4,8554,585
Other undisclosed noncurrent assets (0)270
Total noncurrent assets:9,6499,738
TOTAL ASSETS:13,06710,591
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,785631
Accounts payable1,043287
Accrued liabilities742344
Debt6,4543,132
Derivative instruments and hedges, liabilities2,068598
Other undisclosed current liabilities8,1396,444
Total current liabilities:18,44510,806
Noncurrent Liabilities
Liabilities, other than long-term debt2,099589
Operating lease, liability31 
Derivative instruments and hedges, liabilities2,068589
Other undisclosed noncurrent liabilities4,4221,161
Total noncurrent liabilities:6,5211,750
Total liabilities:24,96612,556
Equity
Equity, attributable to parent, including:(11,900)(5,438)
Common stock808682
Additional paid in capital32,42026,592
Accumulated other comprehensive income (loss)202
Accumulated deficit(48,835)(32,714)
Other undisclosed equity, attributable to parent3,688 
Equity, attributable to noncontrolling interest  1,453
Other undisclosed equity  2,020
Total equity:(11,900)(1,965)
TOTAL LIABILITIES AND EQUITY:13,06710,591

Income Statement (P&L) ($ in thousands)

6/30/2025
TTM
12/31/2024
12/31/2023
Revenues231257
Cost of revenue(11)(1,614)
Cost of product and service sold  (1,614)
Other undisclosed gross profit 1,519
Gross profit:220163
Operating expenses7,529(8,362)
Other undisclosed operating loss(15,057) 
Operating loss:(7,309)(8,199)
Nonoperating expense(6,873)(4,081)
Interest and debt expense216(5,478)
Loss from continuing operations before equity method investments, income taxes:(13,966)(17,758)
Other undisclosed income (loss) from continuing operations before income taxes(216)5,478
Net loss:(14,182)(12,280)
Net income (loss) attributable to noncontrolling interest179(12,280)
Other undisclosed net income attributable to parent 12,265
Net loss attributable to parent:(14,003)(12,294)
Other undisclosed net loss available to common stockholders, basic(161) 
Net loss available to common stockholders, basic:(14,164)(12,294)
Other undisclosed net income available to common stockholders, diluted1,414,965 
Net income (loss) available to common stockholders, diluted:1,400,801(12,294)

Comprehensive Income ($ in thousands)

6/30/2025
TTM
12/31/2024
12/31/2023
Net loss:(14,182)(12,280)
Comprehensive loss:(14,182)(12,280)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest197(12,265)
Comprehensive loss, net of tax, attributable to parent:(13,985)(24,545)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: